← BIO-TECHNE Corp
| Annual Trend | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||||
| Current assets: | |||||||||||
| Cash and Cash Equivalents, at Carrying Value | $64.2m | $91.6m | $122.0m | $100.9m | $146.6m | $199.1m | $172.6m | $180.6m | $151.8m | $162.2m | |
| Short-term Investments | — | — | — | — | — | — | — | $23.7m | $1.1m | — | |
| Inventory, Net | $57.1m | $60.2m | $85.6m | $91.0m | $103.2m | $116.7m | $141.1m | $171.6m | $179.7m | $189.4m | |
| Assets, Current | $253.9m | $348.0m | $398.4m | $412.6m | $520.9m | $510.6m | $605.6m | $621.5m | $617.4m | $608.3m | |
| Property, Plant and Equipment, Net | $132.4m | $135.1m | $145.3m | $154.0m | $176.8m | $207.9m | $223.2m | $226.2m | $251.2m | $245.7m | |
| Goodwill | $430.9m | $579.0m | $597.9m | $732.7m | $728.3m | $843.1m | $822.1m | $872.7m | $972.7m | $980.9m | |
| Intangible Assets, Net (Excluding Goodwill) | $310.5m | $452.0m | $446.3m | $579.4m | $516.5m | $616.0m | $531.5m | $534.6m | $507.1m | $365.6m | |
| Operating Lease, Right-of-Use Asset | — | — | — | — | $71.5m | $73.8m | $65.6m | $98.3m | $91.3m | $73.4m | |
| Other Assets, Noncurrent | $1.9m | $44.0m | $5.3m | $5.7m | $13.5m | $11.6m | $46.8m | $285.3m | $264.3m | $273.6m | |
| Additional Financial Items | |||||||||||
| Accounts Receivable, after Allowance for Credit Loss, Current | $93.4m | $116.8m | $120.3m | $137.5m | $122.5m | $145.4m | $194.5m | $218.5m | $241.4m | $206.9m | |
| Accrued Liabilities, Current | $8.4m | $18.5m | $21.4m | $26.4m | $9.1m | $15.3m | $17.9m | $14.9m | $24.9m | $25.7m | |
| Assets | $1.1b | $1.6b | $1.6b | $1.9b | $2.0b | $2.3b | $2.3b | $2.6b | $2.7b | $2.6b | |
| LIABILITIES AND EQUITY | |||||||||||
| Current liabilities: | |||||||||||
| Operating Lease, Liability, Current | — | — | — | $0 | $9.5m | $11.6m | $11.9m | $11.2m | $12.9m | $14.1m | |
| Accounts Payable, Current | $20.7m | $16.9m | $18.5m | $16.2m | $23.1m | $29.4m | $33.9m | $25.7m | $38.0m | $25.3m | |
| Operating Lease, Liability, Noncurrent | — | — | — | — | $67.2m | $67.6m | $58.1m | $93.8m | $87.6m | $84.0m | |
| Deferred Revenue, Current | $4.7m | $6.0m | $7.1m | — | — | — | — | — | — | — | |
| Long-term Debt, Current Maturities | — | — | — | $12.5m | $12.5m | $12.5m | $12.5m | — | — | — | |
| Liabilities, Current | $54.1m | $135.5m | $79.5m | $102.0m | $106.7m | $152.3m | $176.0m | $128.5m | $159.4m | $175.8m | |
| Deferred Income Tax Liabilities, Net | — | — | — | — | $101.1m | $93.1m | $99.0m | $89.0m | $55.9m | $6.2m | |
| Other Liabilities, Noncurrent | $3.3m | $5.4m | $9.3m | $25.2m | $26.9m | $24.5m | $12.2m | $10.9m | $13.2m | $27.1m | |
| Deferred Tax Liabilities, Net | $62.8m | $120.6m | $86.3m | $89.8m | $101.1m | $93.1m | $99.0m | $89.0m | $55.9m | — | |
| Stockholders’ equity: | |||||||||||
| Common Stock, Value, Issued | $372k | $374k | $376k | $379k | $385k | $390k | $392k | $1.6m | $1.6m | $1.6m | |
| Retained Earnings (Accumulated Deficit) | $770.6m | $799.0m | $876.9m | $931.9m | $1.1b | $1.1b | $1.1b | $1.3b | $1.3b | $1.1b | |
| Accumulated Other Comprehensive Income (Loss), Net of Tax | ($70.4m) | ($48.9m) | ($44.8m) | ($83.5m) | ($97.2m) | ($57.3m) | ($75.2m) | ($66.1m) | ($78.3m) | ($59.9m) | |
| Additional Paid in Capital, Common Stock | $178.8m | $199.2m | $246.6m | $316.8m | $420.5m | $534.4m | $653.7m | $721.5m | $820.3m | $911.1m | |
| Stockholders' Equity Attributable to Parent | $879.3m | $949.6m | $1.1b | $1.2b | $1.4b | $1.6b | $1.7b | $2.0b | $2.1b | — | |
| Stockholders' Equity Attributable to Noncontrolling Interest | — | — | — | — | — | $8.3m | ($759k) | — | — | — | |
| Liabilities and Equity | $1.1b | $1.6b | $1.6b | $1.9b | $2.0b | $2.3b | $2.3b | $2.6b | $2.7b | $2.6b |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.